Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole for Prevention of NSAID-associated Dyspepsia
NCT01140828Phase 3Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- May 2009
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dyspepsia and gastroduodenal ulcer comparing Rabeprazole with Placebo (2 arms). Primary endpoint: 12-week cumulative incidence of gastric/duodenal ulcer, >10 erosions or severe dyspepsia. Started May 2009; status: completed.
02
Drugs
rabeprazole
03
Conditions
dyspepsiagastroduodenal ulcer
Beyond the preview
Go deeper on NCT01140828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01140828.